Your browser doesn't support javascript.
loading
The advantages of switch to subcutaneous bortezomib in the real life.
Mangiacavalli, Silvia; Cocito, Federica; Ferretti, Virginia Valeria; Ganzetti, Maya; Cartia, Claudio Salvatore; Corso, Alessandro.
Affiliation
  • Mangiacavalli S; a Hematology Division, Department of Hematology-Oncology , IRCCS Fondazione Policlinico San Matteo , Pavia , Italy.
  • Cocito F; a Hematology Division, Department of Hematology-Oncology , IRCCS Fondazione Policlinico San Matteo , Pavia , Italy.
  • Ferretti VV; a Hematology Division, Department of Hematology-Oncology , IRCCS Fondazione Policlinico San Matteo , Pavia , Italy.
  • Ganzetti M; a Hematology Division, Department of Hematology-Oncology , IRCCS Fondazione Policlinico San Matteo , Pavia , Italy.
  • Cartia CS; a Hematology Division, Department of Hematology-Oncology , IRCCS Fondazione Policlinico San Matteo , Pavia , Italy.
  • Corso A; a Hematology Division, Department of Hematology-Oncology , IRCCS Fondazione Policlinico San Matteo , Pavia , Italy.
Leuk Lymphoma ; 59(6): 1505-1507, 2018 06.
Article in En | MEDLINE | ID: mdl-28980500

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bortezomib / Multiple Myeloma / Antineoplastic Agents Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2018 Document type: Article Affiliation country: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bortezomib / Multiple Myeloma / Antineoplastic Agents Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2018 Document type: Article Affiliation country: Italy